Akash Pawar

8PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 09, 2026
Prognostic Reclassification and Survival Outcomes in Intermediate-Risk and Poor-Risk Nonseminomatous Germ Cell Tumors: Single-Institution Experience From Western India.

|Aug 12, 2025
Predicting clinical benefit response after neoadjuvant chemotherapy in locally advanced gallbladder cancer: retrospective analysis.

Shraddha Patkar, Kaival Gundavda, Kaushik Polusany

|May 05, 2025
Comprehensive Genomic Profiling of Indian Patients With Lung Cancer.

Shivani Sharma, Vanita Noronha, Arti Yadav

|Mar 07, 2025
Real-World Analysis Evaluating Treatment Eligibility and Outcomes in Patients With AML Receiving Intensive Chemotherapy: Insights From an Underrepresented Population.

Hasmukh Jain, Thomas Eipe, Alok Shetty

|Feb 06, 2025
Prognostic Modeling for Bone Sarcomas Based on a Large Prospective Cohort From a Tertiary Care Cancer Center in India.

Jyoti Bajpai, Laboni Sarkar, Sushmita Rath

|Sep 02, 2024
Phase III randomized trial comparing neoadjuvant paclitaxel plus platinum with 5-fluorouracil plus platinum in esophageal or gastroesophageal junction squamous cell carcinoma.

Vanita Noronha, Vijay Maruti Patil, Nandini Menon

Pageof 2

Frequent Collaborators

4 joint publications

Vanita Noronha

4 joint publications

Kumar Prabhash

2 joint publications

Minit Shah

2 joint publications

Nandini Menon